Toumi M[au] - Search Results

Year	Number of Results
1967	1
1968	1
1969	1
1971	1
1972	1
1973	4
1974	3
1977	3
1988	2
1990	3
1991	3
1992	1
1995	1
1997	1
1998	1
1999	1
2000	2
2002	2
2003	2
2004	4
2005	3
2006	2
2007	9
2008	11
2009	6
2010	12
2011	8
2012	11
2013	17
2014	62
2015	22
2016	24
2017	27
2018	17
2019	26
2020	24
2021	25
2022	21
2023	17
2024	19
2025	4

1

The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK.

Cooper N, Guterres S, Pochopień M, Wilson K, James S, Toumi M, Tytuła A, Rich C, Eriksson D. Cooper N, et al. Among authors: toumi m. J Mark Access Health Policy. 2025 Mar 24;13(2):11. doi: 10.3390/jmahp13020011. eCollection 2025 Jun. J Mark Access Health Policy. 2025. PMID: 40276091 Free PMC article.

2

Clinical Trial Validity Guidance from the HTACG: Looking for Chicken Teeth.

Toumi M, Falissard B, Jouini A, Aballéa S, Boyer L. Toumi M, et al. J Mark Access Health Policy. 2025 Apr 16;13(2):15. doi: 10.3390/jmahp13020015. eCollection 2025 Jun. J Mark Access Health Policy. 2025. PMID: 40276088 Free PMC article. No abstract available.

3

An Economic Model to Assess the Cost Impact of Using Xpert Carba-R to Screen Carbapenemase-Producing Enterobacterales in Comparison with Standard of Care, in a National Health Service Setting.

Toumi M, Pulikottil-Jacob R, Watts K, Odeyemi I, Butler K. Toumi M, et al. Infect Dis Ther. 2025 Apr 19. doi: 10.1007/s40121-025-01141-2. Online ahead of print. Infect Dis Ther. 2025. PMID: 40252171

4

Machine learning-based models for prediction of innovative medicine reimbursement decisions in Scotland.

Wang Y, Tolley K, Francois C, Toumi M. Wang Y, et al. Among authors: toumi m. J Epidemiol Popul Health. 2025 Feb;73(1):202802. doi: 10.1016/j.jeph.2024.202802. Epub 2025 Jan 17. J Epidemiol Popul Health. 2025. PMID: 39826204 Free article.

5

Cost-effectiveness of ten commonly used antipsychotics in first-episode schizophrenia in the UK: economic evaluation based on a de novo discrete event simulation model.

Zhou J, Millier A, Aballea S, Francois C, Jin H, Williams R, Lennox B, Tsiachristas A, Toumi M. Zhou J, et al. Among authors: toumi m. Br J Psychiatry. 2024 Dec 26:1-8. doi: 10.1192/bjp.2024.251. Online ahead of print. Br J Psychiatry. 2024. PMID: 39721946

6

Measuring the Vaccine Success Index: A Framework for Long-Term Economic Evaluation and Monitoring in the Case of Rotavirus Vaccination.

Standaert B, Raes M, Ethgen O, Benninghoff B, Toumi M. Standaert B, et al. Among authors: toumi m. Vaccines (Basel). 2024 Nov 8;12(11):1265. doi: 10.3390/vaccines12111265. Vaccines (Basel). 2024. PMID: 39591168 Free PMC article.

7

Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations for Expanding Valuation by Including Key Concepts.

Biundo E, Dronova M, Chicoye A, Cookson R, Devlin N, Doherty TM, Garcia S, Garcia-Ruiz AJ, Garrison LP, Nolan T, Postma M, Salisbury D, Shah H, Sheikh S, Smith R, Toumi M, Wasem J, Beck E. Biundo E, et al. Among authors: toumi m. Vaccines (Basel). 2024 Jul 15;12(7):773. doi: 10.3390/vaccines12070773. Vaccines (Basel). 2024. PMID: 39066411 Free PMC article.

8

Temporal changes in the morphological and microbial diversity of biofilms on the surface of a submerged stone in the Danube River.

Makk J, Toumi M, Krett G, Lange-Enyedi NT, Schachner-Groehs I, Kirschner AKT, Tóth E. Makk J, et al. Among authors: toumi m. Biol Futur. 2024 Sep;75(3):261-277. doi: 10.1007/s42977-024-00228-0. Epub 2024 Jul 6. Biol Futur. 2024. PMID: 38970754

9

Assessing the validity of a rapid review against a systematic literature review. A comparison of systematic literature reviews done by Cochrane with rapid reviews and the impact on meta-analyses results.

Smela B, Toumi M, Świerk K, Mazurkiewicz A, Klimończyk K, Clay E, Boyer L. Smela B, et al. Among authors: toumi m. J Epidemiol Popul Health. 2024 Aug;72(4):202526. doi: 10.1016/j.jeph.2024.202526. Epub 2024 May 29. J Epidemiol Popul Health. 2024. PMID: 38815496 Free article.

10

Identification of potent inhibitors of kynurenine-3-monooxygenase from natural products: In silico and in vitro approaches.

Rebai R, Carmena-Bargueño M, Toumi ME, Derardja I, Jasmin L, Pérez-Sánchez H, Boudah A. Rebai R, et al. Among authors: toumi me. Heliyon. 2024 Apr 26;10(9):e30287. doi: 10.1016/j.heliyon.2024.e30287. eCollection 2024 May 15. Heliyon. 2024. PMID: 38726174 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

374 results

Results by year